Hinge Health HNGE Ratios (2024-2026)

NYSE HNGE
$92.45 +1.63 (+1.79%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Hinge Health Quarterly Ratios

Periods 9 quarters
Latest Jun 2026

Hinge Health reported a gross margin of 86.44% and a net margin of 20.25% for the quarter ended Jun 2026. These financial ratios cover 9 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin 74.16%78.77%81.95%80.95%70.28%81.84%84.36%84.60%86.44%
EBT Margin -13.99%1.44%22.31%14.65%-414.08%-1.06%18.87%19.72%20.88%
EBIT Margin -19.54%-3.82%17.83%10.61%-417.45%-3.95%15.96%17.59%19.00%
EBITDA Margin -19.54%-3.82%17.83%10.61%-417.45%-3.95%15.96%17.59%19.00%
Operating Margin -19.54%-3.82%17.83%10.61%-417.45%-3.95%15.96%17.59%19.00%
Net Margin -14.39%0.07%23.13%97.97%-413.85%-1.20%18.80%18.66%20.25%
FCF Margin 27.68%31.95%3.41%13.37%52.74%36.28%22.84%46.84%
Efficiency
Inventory AverageInventory Avg. 13.90M14.72M14.90M15.47M
Assets AverageAssets Avg. 731.73M757.28M736.77M778.08M
Asset Utilization RatioAsset Util. 0.730.780.880.93
Valuation
Price to EarningsP/E -7.26-0.00M114.5887.64154.44
Price to SalesP/S 30.0325.0521.5416.3531.28
Price to BookP/B 24.0318.5720.5826.6919.33
Enterprise Value 3,763.37M3,383.46M3,313.65M2,664.98M6,267.27M
EV to EBIT -6.48-555.30121.5783.10154.98
EV to EBITDA -6.48-555.30121.5783.10154.98
Market Capitalization 4,176.63M3,863.49M3,677.51M2,980.85M6,656.67M
Price to FCFP/FCF 224.6147.5059.3771.5966.78
EV to FCF 202.3941.6053.5064.0162.87
EV to CFO 186.0841.0651.8661.8661.80
Return Ratios
Return on Sales [ROS]ROS -19.54%-3.82%17.83%10.61%-417.45%-3.95%15.96%17.59%19.00%
Return on Capital Employed [ROCE]ROCE -147.53%-138.37%-163.65%31.58%
Return on Assets [ROA]ROA -72.87%-69.75%-69.26%14.02%